J&J Wins Blockbuster Approval to Market Xarelto for Stroke Prevention
Mon, Nov 7th 2011
DailyFinance
By Motley Fool Staff Posted 2:56PM 11/05/11 Investing The FDA has given Johnson & Johnson (NYS: JNJ) the green light to market Xarelto to prevent stroke among patients suffering from atrial fibrillation -- opening up a blockbuster market involving more ...
Read more